Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 20, 2025

BUY
$0.88 - $1.88 $20,391 - $43,563
23,172 Added 61.83%
60,650 $55,000
Q4 2024

Feb 10, 2025

BUY
$1.59 - $2.79 $24,409 - $42,832
15,352 Added 69.38%
37,478 $59,000
Q3 2024

Nov 08, 2024

BUY
$1.56 - $2.73 $34,516 - $60,403
22,126 New
22,126 $43,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $124M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.